future glp 1 drugs Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care GLP-1 Agonists Weight Loss Drugs
Description
These shortages reflect production pressure and increase the supply chain pressures
[DOI] [PubMed] [Google Scholar] 624.Green B.D., Hand K.V., Dougan J.E., McDonnell B.M., Cassidy R.S., Grieve D.J
Pharmacodynamic outcomes were extracted if available
The authors suggested that the 37-amino acid peptide homologous in fish and hamster would serve a biologic function
However, they found that there was no significant difference between GLP-1s and SGLT-2s regarding ADRD risk (aHR = 0.97
